Zhejiang Jingxin Pharmaceutical Co.,Ltd.’s Net Profit Rose 6.4% in First Half of 2023

Zhejiang Jingxin Pharmaceutical Co.,Ltd. (浙江京新药业股份有限公司) (002020.SZ) reported a net profit of 318.4 million yuan in the first half of 2023, up 6.4% year-on-year.

Meanwhile, the company posted 1.9 billion yuan in revenue, up 3.4% year-on-year.

At the end of the reporting period, it had 7.6 billion yuan in total assets and 2.3 billion yuan in total liabilities, with a liability-to-asset ratio of 30.8%.